| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Omeprazole impurity 5/Omeprazole EP Impurity E/Omeprazole N-Oxide/4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethylpyridine 1-oxide |
奧美拉唑雜質(zhì) |
176219-04-8 |
詳細(xì)
|
| Sorafenib impurity 7/Methyl 4-(Methylamino)picolinate |
|
1256817-30-7 |
詳細(xì)
|
| Sorafenib impurity 4/4-Deschloro-2-chloro-Sorafenib/4-(4-(3-(2-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide |
|
1431697-81-2 |
詳細(xì)
|
| Racecadotril impurity 3/Racecadotril EP impurity D/5,10-dibenzyl-4,11-dioxo-7,8-dithia-3,12-diazatetradecanedioic acid |
|
123658-06-0 |
詳細(xì)
|
| Ibrutinib impurity 5/(R)-tert-butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-piperidine-1-carboxylate |
|
1022150-11-3 |
詳細(xì)
|
| Sorafenib impurity 20/Sorafenib Hydroxydemethylamine/4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-2-pyridinecarboxylic Acid |
|
1012058-78-4 |
詳細(xì)
|
| Ibrutinib impurity 7/(R)-N-Desacryloyl N-Propionyl Ibrutinib/1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-1-propanone |
|
1839099-22-7 |
詳細(xì)
|
| Safinamide?Acid |
沙芬酰胺雜質(zhì) |
1160513-60-9 |
詳細(xì)
|
| Cimetidine impurity 9/Cimetidine EP Impurity I HCl/(5-ethyl-1H-imidazol-4-yl)methanol hydrochloride |
|
38603-74-6 |
詳細(xì)
|
| Safinamide impurity 1/(S)-2-((4-(benzyloxy)benzyl)amino)propanamide |
|
133865-32-4 |
詳細(xì)
|
| Cimetidine impurity 10/Cimetidine EP Impurity J DiHCl/2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethan-1-amine dihydrochloride |
|
38603-72-4 |
詳細(xì)
|
| Prasugrel impurity 4/Prasugrel Chlorobutyryl Analog/5-(5-chloro-1-(2-fluorophenyl)-2-oxopentyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate |
|
1056459-37-0 |
詳細(xì)
|
| Ibrutinib impurity 2/(S)-Ibrutinib/(S)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one |
|
936563-97-2 |
詳細(xì)
|
| Tedizolid impurity 8/(S)-3-(4-bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one |
|
1369530-77-7 |
詳細(xì)
|
| Vildagliptin Impurity 1/Vildagliptin Diketo Impurity/Vildagliptin Lactam/2-((1r,3s,5R,7S)-3-hydroxyadamantan-1-yl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione |
維格列汀雜質(zhì) |
1789703-36-1 |
詳細(xì)
|
| Solifenacin impurity 3/Solifenacin EP Impurity C/Solifenacin (S,S) Methanone Impurity/Bis[(1S)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinyl]-methanone |
|
1534326-81-2 |
詳細(xì)
|
| Safinamide impurity 9/(S)-2-[3-(2-fluoro-benzyl)-4-(2-fluoro-benzyloxy)-benzylamino]propanamide |
|
1000370-28-4 |
詳細(xì)
|
| Vortioxetine impurity 3/N-(2-chlorophenyl)hydroxylamine |
|
10468-16-3 |
詳細(xì)
|
| LevothyroxineEPImpurityF |
|
911661-90-0 |
詳細(xì)
|
| Omeprazole impurity 11/Omeprazole N-Methyl 5-Methoxy Analog/5-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1-methyl-1H-benzo[d]imidazole |
|
89352-76-1 |
詳細(xì)
|
| Safinamide impurity 7/(R)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propanamide |
|
174756-44-6 |
詳細(xì)
|
| Fasudil impurity 10 |
|
5769-35-7 |
詳細(xì)
|
| Erlotinib impurity 21/6-(2-chloroethoxy)-N-(3-ethynylphenyl)-7-(2-methoxyethoxy)quinazolin-4-amine |
厄洛替尼雜質(zhì) |
183321-83-7 |
詳細(xì)
|
| Erlotinib impurity 6/Erlotinib Hydroxy Metabolite/4-Hydroxy Erlotinib/4-((6,7-bis(2-methoxyethoxy)quinazolin-4-yl)amino)-2-ethynylphenol |
厄洛替尼雜質(zhì) |
882420-22-6 |
詳細(xì)
|
| Vildagliptin Impurity 6/Vildagliptin Dimer Impurity/(2S,2S)-1,1-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)imino]bis(1-oxo-2,1-ethanediyl)]bis[2-Pyrrolidinecarbonitrile] |
維格列汀雜質(zhì) |
1036959-23-5 |
詳細(xì)
|
| Racecadotril impurity 6/Racecadotril EP Imurity H/dibenzyl 5,10-dibenzyl-4,11-dioxo-7,8-dithia-3,12-diazatetradecanedioate |
|
141437-88-9 |
詳細(xì)
|
| Vildagliptin Impurity 13/((1r,3s,5R,7S)-3-hydroxyadamantan-1-yl)glycine |
維格列汀雜質(zhì) |
1032564-18-3 |
詳細(xì)
|
| Rabeprazole impurity 16/(R)-O-Desmethyl Rabeprazole Impurity/(R)-3-((2-(((1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3-methylpyridin-4-yl)oxy)propan-1-ol |
|
179952-04-6 |
詳細(xì)
|
| Cimetidine impurity 5/Cimetidine EP Impurity E/Cimetidine Sulfoxide /2-Cyano-1-methyl-3-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulfinyl]-ethyl]guanidine ; |
|
54237-72-8 |
詳細(xì)
|
| Fasudil impurity 1/Quinoline-5-sulfonic acid |
|
23261-58-7 |
詳細(xì)
|
| Rabeprazole impurity 5/Lansoprazole EP Impurity F Sulfide/4-Desmethoxypropoxyl-4-Chloro Rabeprazole Sulfide/2-[(RS)-[(4-Chloro-3-methylpyridin-2-yl)methyl]sulphinyl]-1H-benzimidazole |
|
103312-62-5 |
詳細(xì)
|
| Safinamide impurity 3/(S)-2-((4-((2-fluorobenzyl)oxy)benzyl)amino)propanamide |
沙芬酰胺雜質(zhì) |
133865-88-0 |
詳細(xì)
|
| Prasugrel impurity 2/Prasugrel Para-Fluoro Isomer/5-(2-cyclopropyl-1-(4-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate |
|
1391194-50-5 |
詳細(xì)
|
| Erlotinib impurity 10/N-(3-bromophenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine |
|
328528-74-1 |
詳細(xì)
|
| Racecadotril impurity 7/Racecadotril Diacid Impurity/3,3-Disulfanediylbis(2-benzylpropanoic acid) |
|
141437-87-8 |
詳細(xì)
|
| Sorafenib impurity 2/Deschloro Sorafenib/N-Methyl-4-[4-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-2-pyridinecarboxamide |
|
1285533-84-7 |
詳細(xì)
|
| Topiroxostat impurity 4/4-Amino-3,5-bis(4-pyridyl)-1,2,4-triazole |
|
38634-05-8 |
詳細(xì)
|
| Palbociclib impurity 1/1-(2-Chloro-4-(cyclopentylamino)pyrimidin-5-yl)ethan-1-one |
|
1244949-62-9 |
詳細(xì)
|
| Tedizolid impurity 11/6,6'-bis(2-methyl-2H-tetrazol-5-yl)-3,3'-bipyridine |
|
2095840-91-6 |
詳細(xì)
|
| Vildagliptin Impurity 16/Vildagliptin Chloroacetyl Nitrile (S)-Isomer/(2S)-1-(Chloroacetyl)-2-Pyrrolidinecarbonitrile |
維格列汀雜質(zhì) |
207557-35-5 |
詳細(xì)
|
| Cimetidine impurity 1/Cimetidine EP Impurity A/Cimetidine Methylsulfanyl Analog /Methyl 3-cyano-1-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl]ethyl] carbamimidothioate |
|
52378-40-2 |
詳細(xì)
|
| Cimetidine impurity 3/Cimetidine EP Impurity C/Cimetidine Amide Impurity/1-[(Methylamino)-[[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl]-ethyl] amino]methylidene]urea |
|
77076-18-7 |
詳細(xì)
|
| Vildagliptin Impurity 5/Vildagliptin Carboxylic Acid/(2s)-1-(2-((3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carboxylic acid |
維格列汀雜質(zhì) |
565453-40-9 |
詳細(xì)
|
| Sorafenib impurity 1/ethyl (4-chloro-3-(trifluoromethyl)phenyl)carbamate |
|
18585-06-3 |
詳細(xì)
|
| Vildagliptin Impurity 17/Vildagliptin Dipyrrolidine Impurity/octahydro-5H,10H-dipyrrolo[1,2-a:1',2'-d]pyrazine-5,10-dione |
維格列汀雜質(zhì) |
6708-06-1 |
詳細(xì)
|
| Sorafenib impurity 8/1-(4-Chloro-3-(trifluoromethyl)phenyl)urea |
|
343247-69-8 |
詳細(xì)
|
| Solifenacin impurity 2/Solifenacin EP Impurity B/(1S)-3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic Acid 1-Methylethyl Ester |
|
1353274-25-5 |
詳細(xì)
|
| Parecoxib impurity 1/N-((3-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide |
|
1709956-89-7 |
詳細(xì)
|
| Safinamide impurity 5/(S)-2-((3-((3-fluorobenzyl)oxy)benzyl)amino)propanamide |
|
861398-52-9 |
詳細(xì)
|
| Omeprazole impurity 18/(R)-Omeprazole/(R)-5-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole |
|
119141-89-8 |
詳細(xì)
|
| Prasugrel impurity 3/5-(2-cyclopropyl-2-oxo-1-phenylethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate |
|
1391194-45-8 |
詳細(xì)
|
| Tedizolid impurity 10/(S)-Tedizolid/(S)-3-(3-fluoro-4-(6-(2-Methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)-5-(hydroxyMethyl)oxazolidin-2-one |
|
1431699-67-0 |
詳細(xì)
|
| Sorafenib impurity 6/4-Chloro-N,N-dimethylpyridine-2-carboxamide |
|
114780-06-2 |
詳細(xì)
|
| Rabeprazole impurity 8/2-(((4-(3-chloropropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole |
|
1613482-73-7 |
詳細(xì)
|
| Rupatadine impurity 1/Rupatadine N-Oxide/3-((4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidin-1-yl)methyl)-5-methylpyridine 1-oxide |
|
1704730-21-1 |
詳細(xì)
|
| 10-Formyl Folic Acid |
10-甲酰葉酸 |
134-05-4 |
詳細(xì)
|
| ZolpidemEPImpurityA |
唑吡坦EP雜質(zhì)A |
1346600-85-8 |
詳細(xì)
|
| Rabeprazole impurity 2/Rabeprazole EP Impurity D/2-(((1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-4-(3-methoxypropoxy)-3-methylpyridine 1-oxide |
|
924663-38-7 |
詳細(xì)
|
| Vortioxetine impurity 1/N,N-Dimethyl-2-nitroaniline |
|
610-17-3 |
詳細(xì)
|
| Solifenacin impurity 1/Solifenacin EP Impurity A/Solifenacin S Isomer/(S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline |
|
118864-75-8 |
詳細(xì)
|
| Fasudil impurity 9/N,N'-Bis(ethylene)-p-Toluenesulfonamide |
|
4403-78-5 |
詳細(xì)
|
| Lansoprazole impurity 4/Lansoprazole EP Impurity F/Rabeprazole Chloro Analog (USP)/Rabeprazole EP Impurity H/2-(((4-Chloro-3-methylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole |
|
168167-42-8 |
詳細(xì)
|
| Omeprazole impurity 9/Omeprazole EP Impurity I/Omeprazole Sulfone N-Oxide/5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphonyl]-1H-benzimidazole N-Oxide |
|
158812-85-2 |
詳細(xì)
|
| Rabeprazole impurity 6/Rabeprazole EP Impurity I/Rabeprazole Sulfone N-Oxide/2-[[[4-(3-Methoxypropoxy)-3-methyl-1-oxido-2-pyridinyl] methyl]sulfonyl]-1H-benzimidazole |
|
924663-37-6 |
詳細(xì)
|
| Omeprazole impurity 17/5-Methoxy-1H-benzimidazole-2-sulfonic acid |
|
106135-28-8 |
詳細(xì)
|
| Sorafenib impurity 5/6-Chloro-N-methylpyridine-2-carboxamide |
|
845306-04-9 |
詳細(xì)
|
| Tedizolid impurity 13/(S)-(3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl) phenyl)-2-oxooxazolidin-5-yl)methyl dihydrogen phosphate |
|
1835340-19-6 |
詳細(xì)
|
| Erlotinib impurity 7/Erlotinib Carboxylic Acid/-(3-((6,7-bis(2-methoxyethoxy)quinazolin-4-yl)amino)phenyl)acetic acid |
厄洛替尼雜質(zhì) |
882420-21-5 |
詳細(xì)
|
| Vildagliptin Impurity 10/Methyl (2S)-1-(2-chloroacetyl)pyrrolidine-2-carboxylate |
維格列汀雜質(zhì) |
38074-72-5 |
詳細(xì)
|
| Zolpidem impurity 2/N,N-dimethyl-2-(6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl)-2-oxoacetamide |
|
400038-68-8 |
詳細(xì)
|
| Vortioxetine impurity 2/1-CHLORO-2-NITROSO-BENZENE |
|
932-33-2 |
詳細(xì)
|
| Ibrutinib impurity 3/
3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
|
330786-24-8 |
詳細(xì)
|
| Erlotinib impurity 20/7-O-Desmethoxy-7-O-chloroethyl Erlotinib/7-(2-chloroethoxy)-N-(3-ethynylphenyl)-6-(2-methoxyethoxy)quinazolin-4-amine |
厄洛替尼雜質(zhì) |
183321-85-9 |
詳細(xì)
|
| Sorafenib impurity 13/Sorafenib Urea Impurity/N-methyl-4-(4-ureidophenoxy)picolinamide |
|
1129683-88-0 |
詳細(xì)
|
| Tedizolid impurity 14/Diphosphoric acid P,P'-bis[[(5R)-3-[3-fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl] ester |
|
1220910-90-6 |
詳細(xì)
|
| Safinamide impurity 2/(S)-2-((4-((4-fluorobenzyl)oxy)benzyl)amino)propanamide |
|
202825-43-2 |
詳細(xì)
|
| Eptifibatide impurity 3/Deamidated Eptifibatide Impurity/(3R,11S,17S,20S,25aS)-20-((1H-indol-3-yl)Methyl)-17-(carboxymethyl)-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-1H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosine-3-carboxylic Acid |
|
618118-95-9 |
詳細(xì)
|
| Rabeprazole impurity 4/Rabeprazole EP Impurity G/Rabeprazole Sulfide 4-Methoxy Analog/2-[[(4-Methoxy-3-methyl-2-pyridinyl)methyl]sulfanyl]-1H-benzimidazole |
|
102804-82-0 |
詳細(xì)
|
| Cimetidine impurity 4/Cimetidine EP Impurity D DiHCl/Cimetidine Descyano DiHCl/1-Methyl-3-[2-[[(5-methyl-1Himidazol-4-yl)methyl]sulfanyl]ethyl]guanidine dihydrochloride |
|
59660-24-1 |
詳細(xì)
|
| Vildagliptin Impurity 15/Vildagliptin Chloroacetyl Nitrile (R)-Isomer/(1S)-2-(2-chloroacetyl)cyclopentane-1-carbonitrile |
維格列汀雜質(zhì) |
565452-98-4 |
詳細(xì)
|
| Selexipag impurity 3/2,3-dichloro-5,6-diphenylpyrazine |
|
57038-62-7 |
詳細(xì)
|
| Vildagliptin Impurity 9/(S)-1-(2-Chloro-acetyl)-pyrrolidine-2-carboxylic acid |
維格列汀雜質(zhì) |
23500-10-9 |
詳細(xì)
|
| Vildagliptin Impurity 8/Vildagliptin Chloroacetyl Amide (S)-Isomer/(S)-1-(2-chloroacetyl)pyrrolidine-2-carboxamide |
維格列汀雜質(zhì) |
214398-99-9 |
詳細(xì)
|
| Prasugrel impurity 1/5-(2-Cyclopropyl-1-(3-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate |
|
1391194-39-0 |
詳細(xì)
|
| Tedizolid impurity 12/(R)-5-(chloromethyl)-3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)oxazolidin-2-one |
|
1239662-46-4 |
詳細(xì)
|
| Flucofuron/1,3-Bis(4-chloro-3-(trifluoromethyl)phenyl)urea |
索拉菲尼雜質(zhì) |
370-50-3 |
詳細(xì)
|
| Omeprazole impurity 4/Omeprazole EP Impurity D/Omeprazole Sulfone/5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphonyl]-1H-benzimidazole |
|
88546-55-8 |
詳細(xì)
|
| Levosimendan impurity 6/Acetamide,N-[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-, (R)- |
|
39052-02-1 |
詳細(xì)
|
| Rabeprazole impurity 3/Rabeprazole EP Impurity E/4-Methoxy Rabeprazole/4-Desmethoxypropoxyl-4-Methoxy Rabeprazole ; 2-[[(4-Methoxy-3-methyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole |
|
102804-77-3 |
詳細(xì)
|
| Racecadotril impurity 2/Racecadotril EP impurity C/[[(2RS)-2-[(acetylsulfanyl)methyl]-3-phenylpropanoyl]amino]acetic acid |
|
124735-06-4 |
詳細(xì)
|
| Racecadotril impurity 4/Racecadotril EP Imurity F/benzyl [(2-benzylprop-2-enoyl)amino]acetate |
|
87428-99-7 |
詳細(xì)
|
| Omeprazole impurity 3/Omeprazole EP Impurity B/4-Desmethoxy Omeprazole/2-[(RS)-[(3,5-Dimethylpyridin-2-yl)methyl]sulphinyl]-5-methoxy-1H-benzimidazole |
|
110374-16-8 |
詳細(xì)
|
| Rupatadine impurity 2/3,5-bis((4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidin-1-yl)methyl)pyridine |
|
1224515-72-3 |
詳細(xì)
|
| Vildagliptin Impurity 20 |
維格列汀雜質(zhì) |
565453-41-0 |
詳細(xì)
|
| Erlotinib impurity 9/6-O-Desmethoxyethyl-6-O-chloroethyl Erlotinib Hydrochloride/6-(2-chloroethoxy)-N-(3-ethynylphenyl)-7-(2-methoxyethoxy)quinazolin-4-amine hydrochloride |
|
183320-04-9 |
詳細(xì)
|
| Vildagliptin Impurity 14/(R)-Vildagliptin/(R)-1-(((1r,3S,5R,7S)-3-hydroxyadamantan-1-yl)glycyl)pyrrolidine-2-carbonitrile |
維格列汀雜質(zhì) |
1036959-27-9 |
詳細(xì)
|
| Vildagliptin Impurity 7/Vildagliptin Amide Impurity/N-(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)glycyl-L-prolinamide |
維格列汀雜質(zhì) |
565453-39-6 |
詳細(xì)
|
| SafinamideImpurity7 |
沙芬酰胺雜質(zhì) |
690969-16-5 |
詳細(xì)
|
| Vildagliptin Impurity 3/Vildagliptin Mono Keto Impurity/Hexahydro-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-1-imino- pyrrolo[1,2-a]pyraz |
|
1789703-37-2 |
詳細(xì)
|
| Sorafenib impurity 23/Sorafenib N-Oxide/4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-2-(methylcarbamoyl)pyridine 1-oxide |
|
583840-03-3 |
詳細(xì)
|